COVID-19: Roche and Regeneron join forces in the vaccine race

The Swiss pharmaceutical company Roche announced on Wednesday an agreement with the American Regeneron for the manufacture and distribution of a vaccine against COVID-19 in the final phase of clinical trials. “Roche and Regeneron announced today that they are joining forces in the fight against COVID-19 to develop, manufacture and distribute REGN-COV2, Regeneron’s experimental antiviral … Read more